FindTrial
Sign In

Prospective randomized comparative study on efficacy of somatostatin and endoscopy combination therapy versus endoscopy in treatment of gastroesphageal variceal hemorrhage

Prospective randomized comparative study on efficacy of somatostatin and endoscopy combination therapy versus endoscopy in treatment of gastroesphageal variceal hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001246
Enrollment
Unknown
Registered
2011-03-31
Start date
2011-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesphageal variceal hemorrhage

Interventions

Group A:Somatostatin and endoscopy combination therapy in treatment of gastroesphageal variceal hemorrhage
Group B:Endoscopy in treatment of gastroesphageal variceal hemorrhage

Sponsors

Department of Gastroenterology of the General Hospital of Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with active bleeding or gastroesphageal variceal bleeding or accompany with high risk signs (red striation, white variceal embolism).

Exclusion criteria

Exclusion criteria: 1. Allergic to the drugs; 2. Pregnant or lactation women; 3. kidney dysfunction; and bilestone syndrome.

Design outcomes

Primary

MeasureTime frame
recrudescence rebleeding rate;—

Secondary

MeasureTime frame
the rate of complication;—

Countries

China

Contacts

Public ContactEn-qiang Linghu
linghuenqiang@vip.sina.com+86 13501233558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026